Biotech Startups

Piezolabs Medical is developing an implantable venous valve platform for patients with severe chronic venous disease, specifically advanced CEAP C5 and C6 stages where venous ulcers recur or fail to heal. The device focuses on durable valve function and physiologic hemodynamics, and is an investigational device not yet cleared or approved for sale.

1 investor

Pilatus Biosciences develops first-in-class antibodies and bifunctional proteins that target metabolic checkpoints to reprogram the immune microenvironment for treating cancer and immune-related diseases. Its lead candidate, an anti-CD36 monoclonal antibody, is in Phase 1 clinical trials for advanced solid tumors.

1 investor

Latent Labs develops AI tools for drug discovery and design, enabling biotech and pharmaceutical companies to accelerate therapeutic molecule identification. The platform democratizes access to advanced generative AI models, reducing the need for in-house AI development capabilities.

1 investor

PinCell is a biotech company developing pharmaceutical treatments in the field of dermatology, based on research into skin biology and skin disorders. It is founded by academic dermatology researchers and holds patents on drug candidates.

1 investor

Pine Tree Therapeutics develops therapies based on targeted protein degradation, with a focus on addressing drug resistance. Its work centers on oncology and related disease areas.

1 investor

Pinova Therapeutics is developing a ready-to-use, low-cost Naloxone product with an enhanced dosage form intended for over-the-counter access. It aims to reduce cost and access barriers to opioid overdose reversal medication for consumers and institutions.

1 investor

Pionarus develops synthetically produced, precision-designed cannabinoid compounds targeting women's health conditions such as menopause and metabolic disease. The company focuses on pharmaceutical-grade cannabinoid therapies optimized for target selectivity, oral bioavailability, and regulatory clarity.

1 investor

Pioneer Biolabs develops reagents and kits for constructing DNA libraries, including sgRNA capture adapters and magnetic bead-based workflows aimed at researchers working with small amounts of DNA. The company also plans to offer library construction services and tools for laboratory experiments.

1 investor

Pipeline Pharma provides a database and intelligence platform for pharmaceutical companies to analyze competitive landscapes, regulatory pipelines, and sourcing opportunities across drug molecules and therapeutic areas. The platform enables investment decisions, portfolio optimization, and commercial supplier comparisons through access to over 82,500 clinical trial dossiers globally.

1 investor

PIRCHE develops immunogenicity prediction tools for transplant medicine, using HLA epitope analysis to predict how a recipient's immune system will respond to a donor organ or cells. Its TxPredictor platform serves clinicians and laboratories across solid organ, stem cell, and allogeneic cell therapy settings for risk stratification, donor selection, and guiding immunosuppression.

1 investor

Pirouette develops self-injection devices for chronic condition management at home, featuring hidden-needle technology to reduce injection anxiety. The company manufactures its OnePush platform using automated production capabilities in New Hampshire.

1 investor

Pixl.bio produces iPSC-derived hepatic stellate cells for liver disease modeling and fibrosis research. The cells are used in studies of metabolic-associated fatty liver disease (MASLD), steatohepatitis, and chronic liver injury.

1 investor

Place Genomics develops DNA nanotechnology and next-generation sequencing (NGS) sample preparation technologies for genomic research and precision medicine applications. The company focuses on genomics innovations for use in health and medicine.

1 investor

PLAIO offers demand planning software that uses machine learning and statistical models to forecast future demand by analyzing historical data and market inputs, serving businesses across industries including pharmaceuticals. The platform consolidates forecasts and purchase orders while maintaining human oversight through manual overrides and audit trails, and integrates with ERP systems like SAP.

1 investor

Planasa breeds and develops superior berry varieties including blueberries, raspberries, strawberries, and blackberries, along with garlic, asparagus, and avocado, using traditional and modern breeding methods for distribution through nursery operations to growers worldwide.

1 investor

Planet Biotech develops plant biotechnology products and active ingredients for sustainable agriculture that increase crop resilience to drought and heat stress. The company serves farmers and agribusiness by commercializing science-based solutions to address food security and climate change impacts.

1 investor

Plant Health Care develops biological crop products, including patented harpin-based proteins and peptides marketed as "vaccines for plants" that act as biostimulants and boost plants' natural disease resistance to improve yield and quality. It sells products such as Harpinαß and PHC279 to farmers worldwide through specialist distributors and its PREtec platform, and is a wholly owned subsidiary of PI Industries Ltd of India.

1 investor

Plantner extracts and manufactures alginate, a biodegradable material used across biomedical and industrial applications. Its alginate is applied in medical devices, pharmaceuticals, cosmetics, advanced biotech (such as bio-ink and organoids), and agriculture.

1 investor

PlantSustain develops biological crop inputs using naturally symbiotic bacteria and fungi to replace chemical fertilizers and pesticides, aiming to improve plant health, resilience, and nutrient uptake for farmers. It commercializes biological innovation from research institutions and universities for the agriculture industry.

1 investor

PLAS-FREE develops medical devices that remove specific substances from blood products to treat life-threatening conditions such as hemorrhage and hepatic encephalopathy. The company targets hospitals and blood transfusion centers with devices designed for emergency and critical care settings.

1 investor

Ingredient Optimized is a biotechnology company that uses non-thermal atmospheric plasma to modify protein structure, producing clinically researched branded proteins designed for higher bioavailability, better absorption, reduced stomach discomfort, and improved taste compared to standard protein isolates. Its optimized ingredients target the nutrition and protein supplement market.

1 investor

PlasmaGen BioSciences is a biopharmaceutical company focused on plasma protein and specialty care therapies, offering products across medical specialities such as neurology, haematology, oncology, immunology and critical care. It serves patients in India and other developing economies, working with government bodies on affordability, accessibility and hemovigilance.

1 investor

PlasmidFactory is a contract development and manufacturing organization (CDMO) that produces plasmid DNA and proprietary Minicircle DNA for research, preclinical, and GMP applications in gene and cell therapy, viral vectors, and vaccine development. It serves biotech and pharmaceutical clients developing advanced therapies, offering DNA production across defined quality grades up to GMP standards.

1 investor

Plasmidsaurus provides fast DNA and RNA sequencing services for scientists, including whole plasmid, whole genome, amplicon, microbiome, RNA-Seq, and AAV sequencing, with bioinformatics tools and annotated data delivered overnight. It serves academic researchers, pharma companies, and life-science labs, offering sample submission via a global network of dropboxes.

1 investor